A detailed history of Virtus ETF Advisers LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 14,222 shares of WVE stock, worth $205,507. This represents 0.06% of its overall portfolio holdings.

Number of Shares
14,222
Previous 13,970 1.8%
Holding current value
$205,507
Previous $69,000 68.12%
% of portfolio
0.06%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.12 - $9.01 $1,290 - $2,270
252 Added 1.8%
14,222 $116,000
Q2 2024

Aug 14, 2024

BUY
$4.38 - $6.48 $61,188 - $90,525
13,970 New
13,970 $69,000
Q4 2021

Feb 14, 2022

SELL
$3.14 - $5.15 $91,342 - $149,813
-29,090 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$4.89 - $7.12 $7,383 - $10,751
-1,510 Reduced 4.93%
29,090 $143,000
Q2 2021

Aug 10, 2021

SELL
$5.65 - $7.47 $11,316 - $14,962
-2,003 Reduced 6.14%
30,600 $204,000
Q1 2021

May 17, 2021

BUY
$5.61 - $12.01 $3,203 - $6,857
571 Added 1.78%
32,603 $183,000
Q4 2020

Feb 12, 2021

BUY
$6.99 - $9.26 $111 - $148
16 Added 0.05%
32,032 $252,000
Q3 2020

Nov 13, 2020

SELL
$8.49 - $19.54 $36,889 - $84,901
-4,345 Reduced 11.95%
32,016 $272,000
Q2 2020

Aug 05, 2020

BUY
$7.44 - $11.29 $199,414 - $302,605
26,803 Added 280.42%
36,361 $379,000
Q1 2020

May 14, 2020

SELL
$6.94 - $14.22 $9,646 - $19,765
-1,390 Reduced 12.7%
9,558 $90,000
Q4 2019

Feb 13, 2020

BUY
$7.99 - $37.6 $8,860 - $41,698
1,109 Added 11.27%
10,948 $88,000
Q3 2019

Nov 12, 2019

SELL
$19.17 - $27.4 $10,505 - $15,015
-548 Reduced 5.28%
9,839 $202,000
Q2 2019

Aug 13, 2019

BUY
$22.93 - $42.84 $114,971 - $214,799
5,014 Added 93.32%
10,387 $271,000
Q1 2019

May 14, 2019

SELL
$32.69 - $47.91 $20,038 - $29,368
-613 Reduced 10.24%
5,373 $209,000
Q4 2018

Feb 05, 2019

BUY
$37.1 - $50.11 $222,080 - $299,958
5,986 New
5,986 $252,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.25B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.